Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in

Mathieu Marella1, Cédric Gaggioli, Michèle Batoz

  • 1Institut de Pharmacologie Moléculaire et Cellulaire, Unité Mixte de Recherche 6097, Centre National de la Recherche Scientifique 660, route des lucioles, 06560 Valbonne, France.

Insights

Pathological prion protein (PrPres) triggers microglial cell recruitment by activating the mitogen-activated protein kinase pathway in neurons. This pathway up-regulates chemokines, influencing prion disease progression.

Area of Science:

  • Neuroscience
  • Immunology
  • Prion Diseases

Background:

  • Transmissible spongiform encephalopathies involve microglial cell recruitment near pathological prion protein (PrPres) aggregates.
  • PrPres interaction with neurons up-regulates chemokines like RANTES, but intracellular mechanisms remain unclear.

Purpose of the Study:

  • To elucidate the intracellular mechanisms of PrPres-induced chemokine expression in neurons.
  • To investigate the role of the mitogen-activated protein kinase (MAPK) pathway in this process.

Main Methods:

  • Neuronal exposure to PrPres.
  • Analysis of MAPK pathway activation and transcription factor Egr-1 expression.
  • Inhibition of MAPK pathway using PD98059.
  • Neuronal overexpression of Nab2, an Egr-1 corepressor.

Main Results:

  • PrPres exposure activates the MAPK pathway in neurons, leading to Early Growth Response factor-1 (Egr-1) expression.
  • MAPK pathway activation up-regulates RANTES mRNA expression.
  • Inhibition of MAPK signaling or Nab2 overexpression reduced RANTES expression and microglial migration.
  • PrPres-induced chemoattraction is independent of PrPc and laminin receptor.

Conclusions:

  • The MAPK signaling pathway acts as a master switch for neuronal expression of chemoattraction regulators in response to PrPres.
  • This finding clarifies a key mechanism in prion disease pathogenesis and neuroinflammation.